Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial

Joël Shapiro(Erasmus University Rotterdam), J. Jan B. van Lanschot(Erasmus University Rotterdam), Maarten C.C.M. Hulshof(Academic Medical Center), Pieter van Hagen(Erasmus MC), Mark I. van Berge Henegouwen(Academic Medical Center), Bas P. L. Wijnhoven(Erasmus MC), Hanneke W.M. van Laarhoven(Academic Medical Center), Grard A. P. Nieuwenhuijzen(Catharina Ziekenhuis), Geke A.P. Hospers(University Medical Center Groningen), Johannes J. Bonenkamp(Radboud University Medical Center), Miguel A. Cuesta(Amsterdam UMC Location VUmc), R.J.B. Blaisse(Rijnstate Hospital), Olivier R. Busch(Academic Medical Center), Fiebo J.W. ten Kate(Erasmus MC), Geert-Jan Creemers(Radboud University Nijmegen), Cornelis J.A. Punt(Radboud University Nijmegen), John Th. M. Plukker(University Medical Center Groningen), Henk M.W. Verheul(Amsterdam UMC Location VUmc), Ernst Jan Spillenaar Bilgen(Rijnstate Hospital), Herman van Dekken(Sint Lucas Andreas Hospital), Maurice J.C. van der Sangen(Catharina Ziekenhuis), Tom Rozema(Radboud University Medical Center), Katharina Biermann(Erasmus University Rotterdam), Jannet C. Beukema(University Medical Center Groningen), Anna H.M. Piet(Amsterdam UMC Location VUmc), Caroline M. van Rij(Erasmus University Rotterdam), Janny G. Reinders(Dutch Art Institute), Hugo W. Tilanus(Erasmus University Rotterdam), Ewout W. Steyerberg(Erasmus MC), Ate van der Gaast(Erasmus MC)
The Lancet Oncology
August 6, 2015
Cited by 2,535

Abstract


Related Papers

No related papers found

Powered by citation graph analysis